Do you want to read an article? Please log in or register.
Comparing encounter-based and annualized chronic pseudomonas infection definitions in cystic fibrosis
Pulmonary Fibrosis
RECOMMENDED
Related content
RECOMMENDED
Bronchi
Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials
Lancet Respir Med.
Haworth CS, Bilton D, Chalmers JD, Davis AM, Froehlich J, Gonda I, Thompson B, Wanner A, O'Donnell AE
doi: 10.1016/S2213-2600(18)30427-2.
Pulmonary Fibrosis
Meropenem combined with ciprofloxacin combats hypermutable Pseudomonas aeruginosa from respiratory infections of cystic fibrosis patients
Antimicrob Agents Chemother.
Rees VE, Yadav R, Rogers KE, Bulitta JB, Wirth V, Oliver A, Boyce JD, Peleg AY, Nation RL, Landersdorfer CB
doi: 10.1128/AAC.01150-18.
Asthma
Reconciling Antimicrobial Susceptibility Testing and Clinical Response in Antimicrobial Treatment of Chronic Cystic Fibrosis Lung Infections
Clin Infect Dis.
Waters VJ, Kidd TJ, Canton R, Ekkelenkamp MB, Johansen HK, LiPuma JJ, Bell SC, Elborn JS, Flume PA, VanDevanter DR, Gilligan P, Antimicrobial Resistance International Working Group in Cystic Fibrosis.
doi: 10.1093/cid/ciz364.
RECOMMENDED
Pulmonary Fibrosis
Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis. The OPTIMIZE Randomized Trial
Am J Respir Crit Care Med.
Mayer-Hamblett N, Retsch-Bogart G, Kloster M, Accurso F, Rosenfeld M, Albers G, Black P, Brown P, Cairns A, Davis SD, Graff GR, Kerby GS, Orenstein D, Buckingham R, Ramsey BW; OPTIMIZE Study Group
doi: 10.1164/rccm.
RECOMMENDED
Pulmonary Fibrosis
Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis
J Cyst Fibros.
Bilton D, Pressler T, Fajac I, Clancy JP, Sands D, Minic P, Cipolli M, Galeva I, Solé A, Quittner AL, Liu K, McGinnis JP 2nd, Eagle G, Gupta R, Konstan MW, CLEAR-108 Study Group.
doi: 10.1016/j.jcf.2019.08.001.
RECOMMENDED
Bronchi
Infection prevention and chronic disease management in cystic fibrosis and noncystic fibrosis bronchiectasis
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Ther Adv Respir Dis.
Lommatzsch ST
doi: 10.1177/1753466620905272.
Pulmonary Fibrosis
Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection
Ther Adv Respir Dis.
Greenwood J, Schwarz C, Sommerwerck U, Nash EF, Tamm M, Cao W, Mastoridis P, Debonnett L, Hamed K
doi: 10.1177/
RECOMMENDED
Pulmonary Fibrosis
Clinical characteristics and outcomes associated with Inquilinus infection in cystic fibrosis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
J Cyst Fibros.
Lenhart-Pendergrass PM, Caverly LJ, Wagner BD, Sagel SD, Nick JA, LiPuma JJ, Martiniano SL
doi: 10.1016/j.jcf.2020.07.011.
Pulmonary FibrosisPneumonia
Progress in Definition, Prevention and Treatment of Fungal Infections in Cystic Fibrosis
Mycopathologia.
Schwarz C, Hartl D, Eickmeier O, Hector A, Benden C, Durieu I, Sole A, Gartner S, Milla CE, Barry PJ
doi: 10.1007/s11046-017-0182-0.